trending Market Intelligence /marketintelligence/en/news-insights/trending/okXPbDVagkOiyVN83q250Q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

MacroGenics expands board, adds 2 directors

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


MacroGenics expands board, adds 2 directors

MacroGenics Inc. expanded its board to eight members and appointed Karen Ferrante and Scott Jackson to fill the new vacancies.

Ferrante, who recently served as chief medical officer and head of research and development at Tokai Pharmaceuticals Inc., will serve on the MacroGenics nominating & corporate governance committee. Jackson, who previously served as CEO of Celator Pharmaceuticals Inc., will sit on the compensation committee.